Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...

The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...

The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests. Next-generation sequencing tests review a person’s DNA to diagnose ...

Next-generation DNA sequencing (NGS) has transformed the way scientists understand genetics. With the ability to sequence DNA and RNA faster and cheaper than ever before, this technology is reshaping ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...

Research has warned that your DNA data can be hacked into and used against you by exploiting certain vulnerabilities in modern techniques. A study published in IEEE Access has revealed weaknesses in ...

This workshop explored the current use of DNA sequencing in newborns as well as the potential benefits and harms, associated ethical and data security issues, and equity in access to screening. A ...

The workshop examined the use of DNA sequencing to supplement traditional newborn screening for conditions that are treatable but not clinically evident in the newborn phase. This infographic provides ...